Novartis Agrees to Acquire Avidity Biosciences for $12 Billion
The Swiss pharmaceutical company says the purchase would complement its existing pipeline of treatments for neuromuscle disorders.
—-
Corruption Probe Underway at…

Novartis Agrees to Acquire Avidity Biosciences for $12 Billion
The Swiss pharmaceutical company says the purchase would complement its existing pipeline of treatments for neuromuscle disorders.
—-
Corruption Probe Underway at…
STOCKHOLM, Oct. 26, 2025 /PRNewswire/ — BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that Health Canada has issued a Notice of Compliance with…

By Rhiannon Hoyle
A Rio Tinto-controlled company has asked law enforcement to help with an investigation into allegations of corruption and unethical conduct at the giant Oyu Tolgoi copper operation in Mongolia.
"We are aware of...

In China, ESCC stays the most prevalent histological subtype of esophageal cancer,1 with Hebei Province reporting particularly high incidence rates.2–4 Despite notable progress in diagnostic approaches and therapeutic regimens, the…

Atherosclerotic cardiovascular disease (ASCVD) continues to be a major cause of morbidity and mortality in the United States and the rest of the world, fueled by ongoing increases in hypertension, obesity, type 2 diabetes and other…


This article first appeared on GuruFocus.
Revenue: Record $2.4 billion, up 8% year on year and 5% sequentially.
Comparable EBITDA: Increased 3% sequentially; nine-month comparable EBITDA at $722 million.
Turkey Breast Prices: Reached…

The trade-reliant country’s growth print comes as investors watch for Trump’s meeting with South Korean President Lee Jae-myung on the sidelines of APEC in Gyeongju. The two sides have yet to finalize a trade deal, with officials looking to…